These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38831012)

  • 1. Identifying patients with undiagnosed small intestinal neuroendocrine tumours in primary care using statistical and machine learning: model development and validation study.
    Clift AK; Mahon H; Khan G; Boardman-Pretty F; Worker A; Marchini E; Buendia O; Fish P; Khan MS
    Br J Cancer; 2024 Jul; 131(2):305-311. PubMed ID: 38831012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenteric tumour deposits arising from small-intestine neuroendocrine tumours are frequently associated with fibrosis and IgG4-expressing plasma cells.
    Roberts J; Gonzalez RS; Revetta F; Shi C
    Histopathology; 2018 Nov; 73(5):795-800. PubMed ID: 29943407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.
    Folkestad O; Wasmuth HH; Mjønes P; Fougner R; Hauso Ø; Fossmark R
    Surg Oncol; 2020 Dec; 35():336-343. PubMed ID: 32979699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of metastases outside the liver and abdominal lymph nodes on
    Wedin M; Janson ET; Wallin G; Sundin A; Daskalakis K
    J Neuroendocrinol; 2024 May; 36(5):e13391. PubMed ID: 38590270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine tumours of the small bowel: interpretation of raised circulating chromogranin A, urinary 5 hydroxy indole acetic acid and circulating neurokinin A.
    Ardill JE; Armstrong L; Smye M; Doherty R; McCance DR; Johnston BT
    QJM; 2016 Feb; 109(2):111-5. PubMed ID: 25979268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and survival of patients with small intestinal neuroendocrine tumours in a Danish NET center.
    Hoej LB; Nykjær KM; Gronbaek H
    ScientificWorldJournal; 2012; 2012():206350. PubMed ID: 23304081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsule endoscopy to detect primary tumour site in metastatic neuroendocrine tumours.
    Frilling A; Smith G; Clift AK; Martin J
    Dig Liver Dis; 2014 Nov; 46(11):1038-42. PubMed ID: 25086997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
    Francis JM; Kiezun A; Ramos AH; Serra S; Pedamallu CS; Qian ZR; Banck MS; Kanwar R; Kulkarni AA; Karpathakis A; Manzo V; Contractor T; Philips J; Nickerson E; Pho N; Hooshmand SM; Brais LK; Lawrence MS; Pugh T; McKenna A; Sivachenko A; Cibulskis K; Carter SL; Ojesina AI; Freeman S; Jones RT; Voet D; Saksena G; Auclair D; Onofrio R; Shefler E; Sougnez C; Grimsby J; Green L; Lennon N; Meyer T; Caplin M; Chung DC; Beutler AS; Ogino S; Thirlwell C; Shivdasani R; Asa SL; Harris CR; Getz G; Kulke M; Meyerson M
    Nat Genet; 2013 Dec; 45(12):1483-6. PubMed ID: 24185511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-Related Quality of Life in Patients with Small Intestine Neuroendocrine Tumors.
    Karppinen N; Lindén R; Sintonen H; Tarkkanen M; Roine R; Heiskanen I; Matikainen N; Schalin-Jäntti C
    Neuroendocrinology; 2018; 107(4):366-374. PubMed ID: 30293074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms.
    Maurer E; Heinzel-Gutenbrunner M; Rinke A; Rütz J; Holzer K; Figiel J; Luster M; Bartsch DK
    J Neuroendocrinol; 2022 Jan; 34(1):e13076. PubMed ID: 34964186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of, phenotypes of and survival from small bowel cancer in Denmark, 1994-2010: a population-based study.
    Bojesen RD; Andersson M; Riis LB; Nielsen OH; Jess T
    J Gastroenterol; 2016 Sep; 51(9):891-9. PubMed ID: 26847562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and prognosis of malignant small bowel tumors: Experience from a university hospital in Chile.
    Silva F; Bustamante M; Latorre G; Flandez J; Montero I; Dukes E; Gandara V; Robles C; Uribe J; Iglesias A; Bellolio F; Molina ME; Migueles R; Urrejola G; Larach T; Besser N; Sharp A; Agüero C; Riquelme A; Vargas JI; Candia R; Monrroy H; De Simone F; Espino A
    Gastroenterol Hepatol; 2024 May; 47(5):491-499. PubMed ID: 38331316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours.
    Söderquist F; Janson ET; Rasmusson AJ; Ali A; Stridsberg M; Cunningham JL
    PLoS One; 2016; 11(10):e0164354. PubMed ID: 27736994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013-2015.
    Genus TSE; Bouvier C; Wong KF; Srirajaskanthan R; Rous BA; Talbot DC; Valle JW; Khan M; Pearce N; Elshafie M; Reed NS; Morgan E; Deas A; White C; Huws D; Ramage J
    Br J Cancer; 2019 Nov; 121(11):966-972. PubMed ID: 31649320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on medical treatment of small intestinal neuroendocrine tumors.
    Pusceddu S; Femia D; Lo Russo G; Ortolani S; Milione M; Maccauro M; Vernieri C; Prinzi N; Concas L; Leuzzi L; De Braud F; Buzzoni R
    Expert Rev Anticancer Ther; 2016 Sep; 16(9):969-76. PubMed ID: 27353232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-cancer risk stratification based on national health data: a retrospective modelling and validation study.
    Jung AW; Holm PC; Gaurav K; Hjaltelin JX; Placido D; Mortensen LH; Birney E; Brunak SR; Gerstung M
    Lancet Digit Health; 2024 Jun; 6(6):e396-e406. PubMed ID: 38789140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management Strategies and Outcomes for Small Intestinal Neuroendocrine Tumours with Involvement of the Superior Mesenteric Vessels: A Systematic Review.
    Kmiotek E; Lakda S; Borakati A; Ogunbiyi O; Mandair D; Caplin M; Toumpanakis C; Mirnezami R
    Curr Oncol; 2023 Oct; 30(10):9192-9204. PubMed ID: 37887564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Threshold for Circulating Tumor Cells in Patients With Pancreatic and Midgut Neuroendocrine Tumors.
    Mandair D; Khan MS; Lopes A; Furtado O'Mahony L; Ensell L; Lowe H; Hartley JA; Toumpanakis C; Caplin M; Meyer T
    J Clin Endocrinol Metab; 2021 Mar; 106(3):872-882. PubMed ID: 33180939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study.
    Snorradottir S; Asgeirsdottir A; Rögnvaldsson S; Jonasson JG; Björnsson ES
    Cancer Epidemiol; 2022 Aug; 79():102197. PubMed ID: 35716441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.
    Ahmed A; Turner G; King B; Jones L; Culliford D; McCance D; Ardill J; Johnston BT; Poston G; Rees M; Buxton-Thomas M; Caplin M; Ramage JK
    Endocr Relat Cancer; 2009 Sep; 16(3):885-94. PubMed ID: 19458024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.